Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$1.6 million.

  • Lemaitre Vascular's Net Cash Flow rose 753.11% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 7348.07%. This contributed to the annual value of $2.1 million for FY2024, which is 5706.42% down from last year.
  • Lemaitre Vascular's Net Cash Flow amounted to -$1.6 million in Q3 2025, which was up 753.11% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Net Cash Flow registered a high of $5.8 million during Q4 2023, and its lowest value of -$4.2 million during Q2 2024.
  • Over the past 5 years, Lemaitre Vascular's median Net Cash Flow value was -$1.2 million (recorded in 2023), while the average stood at -$24368.4.
  • In the last 5 years, Lemaitre Vascular's Net Cash Flow plummeted by 41143.85% in 2021 and then surged by 37837.57% in 2022.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Net Cash Flow stood at -$3.3 million in 2021, then surged by 146.37% to $1.6 million in 2022, then surged by 273.41% to $5.8 million in 2023, then decreased by 7.38% to $5.4 million in 2024, then plummeted by 130.4% to -$1.6 million in 2025.
  • Its Net Cash Flow stands at -$1.6 million for Q3 2025, versus $1.2 million for Q2 2025 and -$520000.0 for Q1 2025.